Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Efbemalenograstim alfa (F 627) is a recombinant fusion protein comprising a long-acting dimeric granulocyte colony-stimulating factor (G-CSF) with two human G-CSF molecules connected via a peptide linker to a human immunoglobulin G2 (hIgG2)-Fc fragment. This biopharmaceutical agent induces the production of white blood cells [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Efbemalenograstim alfa (F 627) is a recombinant fusion protein comprising a long-acting dimeric granulocyte colony-stimulating factor (G-CSF) with two human G-CSF molecules connected via a peptide linker to a human immunoglobulin G2 (hIgG2)-Fc fragment. This biopharmaceutical agent induces the production of white blood cells [1]. |
Synonyms | F 627, Bineuta, Benegrastim |
Molecular Weight | N/A |
CAS No. | 2200269-79-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Efbemalenograstim alfa 2200269-79-8 F627 F 627 Bineuta F-627 Benegrastim inhibitor inhibit